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The availability of solid state structures of opioid receptors has prompted us to reconsider a
crucial question concerning bioactive peptides: can their conformation be studied without
any knowledge of the structure of their receptors? The possibility of giving a meaningful
answer to this query rests ultimately on the ease of dealing with the flexibility of bioactive
peptides, and amongst them one of the most flexible bioactive peptides, enkephalin.
All solution studies of enkephalin hint at an inextricable mixture of quasi isoenergetic
conformers. In this study we refer to the only NMR work that yielded inter-residue NOEs,
performed at very low temperature. In the present work, we have used the simplest
possible docking methods to check the consistency of the main conformers of enkephalin
with the steric requirements of the active site of the receptor, as provided by the crystal
structure of its complex with naltrindole, a rigid antagonist. We show that the conformers
found in the equilibrium mixture at low temperature are indeed compatible with a good fit
to the receptor active site. The possible uncertainties linked to the different behavior of
agonists and antagonists do not diminish the relevance of the finding.
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INTRODUCTION
The alkaloids of opium have been used for at least the last 4000
years to alleviate pain and for their euphoric effects. Enkephalins,
the first endogenous opioids, are among the best studied bioac-
tive peptides. They are pentapeptides found endogenously in all
vertebrates (Simantov et al., 1976). In nature, they act by inter-
acting with the same receptors that recognize plant opiates. The
information is transmitted to the brain where it is processed to
have effects both in terms of analgesia and drug dependence.
Discovered in 1975 (Hughes et al., 1975), their sequences con-
tain two aromatic residues in the first and fourth position and
two consecutive glycines in position 2 and 3. A semi-conserved
position 5 accommodates equally well leucine or methionine.
Although their affinity for the μ receptor is lower than that of
the most potent alkaloids, both enkephalins are better δ ago-
nists than most alkaloids (Schiller et al., 1992). Because of their
high biological significance and, at the same time, their relatively
modest sequence length, enkephalins were also natural targets
both for structural and theoretical studies attempting to define
the free energy landscape of proteins (Purisima and Scheraga,
1987; Hansmann et al., 1999). Endless experimental studies
both by X-ray crystallography and by NMR were dedicated to
the attempt of capturing the “biologically active conformation”
that is the conformation adopted by enkephalins when inter-
acting with the receptor (reviewed in Spadaccini and Temussi,
2001). The main crystal structures of isolated enkephalins are
still now exhaustively reviewed in a classical analysis (Deschamps
et al., 1996). We adopted a different approach in solution
studies.
Solution studies have shown that enkephalin is very flexible
and exists in most media as a complex mixture of quasi isoener-
getic conformations (Spadaccini and Temussi, 2001). Unraveling
this mixture in terms of a few conformers is extremely difficult,
even by sophisticated calculation approaches based on system-
atic exploration of the free energy landscape (Meirovitch et al.,
1995; Meirovitch and Meirovitch, 1996). In the past, we proposed
a “reverse” strategy which used rigid molecular molds as suitable
filters for conformational searches (Amodeo et al., 1998).
The straightforward strategy generally followed in most solu-
tion studies of small bioactive peptides (e.g., see Temussi et al.,
1989; Crescenzi et al., 1996) implies as a first step the determi-
nation of the most energetically favorable peptide conformers.
These in turn are compared with rigid molds to check the consis-
tency of the shape of the message domain. Finally, the conformers
selected by this filter are used to improve the indirect mapping
of the hypothetical receptor’s active site. Owing to the extreme
difficulty of finding a reasonable number of low energy con-
formers in the huge conformational space of enkephalin, in the
past we adopted a reverse strategy (Amodeo et al., 1998). We
used spectroscopic data only to check whether, even among
simple conformational mixtures of the peptide, there are con-
formers consistent with the shape of rigid alkaloid opioids. Then
we checked whether a mixture composed by a limited number
of these conformers could account for NMR data and energy
requirements. We showed that this is indeed possible by refer-
ring to a naïf equilibrium mixture, representative of the most
common peptide turns. In such a mixture we found the presence
of conformers of Leu-enkephalin consistent with the shape of δ
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selective rigid compounds that, at the same time, could account
for high quality NOE data at low temperature (Amodeo et al.,
1998).
This method allowed us to account for NMR data at low tem-
perature using just a few enkephalin conformers (Amodeo et al.,
1998). However, the identity of the receptor being unknown, these
studies did not find an outcome related to the fit of the active
site. As is true with many other biologically active linear pep-
tides from natural sources, enkephalins are very flexible molecules
that can assume a large number of conformations whose distri-
bution is a function of the environment. Their physiologically
relevant structure cannot easily be determined in the absence of
their natural partners. In the past, there have been many attempts
to circumvent these difficulties, particularly by choosing, in solu-
tion studies, environments as close as possible to natural media
(Pastore and Temussi, 2013).
Despite some successes in the conformational analyses of
enkephalins skepticism has persisted concerning the significance
of these studies: does the bioactive conformation exist at all
among the many conformations accessible to the receptor free
peptide? This question is crucial also in view of the newly iden-
tified family of intrinsically unfolded proteins, that is, proteins
which adopt a specific conformation only upon binding to their
partners. Recently the structures of the three μ, δ, and κ opi-
oid receptors were solved by crystallography (Granier et al., 2012;
Manglik et al., 2012; Wu et al., 2012; Fenalti et al., 2014). The
active sites of μ, δ, and κ receptors can be described as “exposed
binding pockets,” similar in shape but differing in the residues
lining the walls. This major breakthrough naturally opens the
possibility of validating the results from previous conformational
studies and, more interestingly, of understanding the molecular
basis of the opioid-receptor interaction.
We can now show how availability of the structure of the
δ selective opioid receptor and a rationally instructed docking
approach leads us to find a receptor-bound conformation of
enkephalin which is fully compatible with previous NMR studies.
In particular, the two bioactive conformers described in this study
are those found by the mentioned “reverse” strategy (Amodeo
et al., 1998). Our studies have also important ramifications for
studies of intrinsically unfolded proteins whose study is at present
as trendy as that of “biologically active peptides” was a few
decades ago (Pastore and Temussi, 2013) and their significance
for defining crucial interactions with already folded proteins.
METHODS
Preliminary screening of a few hypothetical candidates of
enkephalin bioactive conformation, coming from solid state
studies or from a low temperature NMR study, was performed
by superimposing the tyrosine aromatic ring of enkephalin
conformers with the corresponding ring of Naltrindole.
Superpositions were made using MOLMOL (Koradi et al., 1996).
VIRTUAL SCREENING
The crystal structure of the Human δ opioid 7TM receptor
was obtained from the Protein Data Bank (PDB) (id: 4N6H)
(Fenalti et al., 2014) and edited for docking calculations using
AutoDockTools 1.5.6 software: Na+ ion, naltrindole and water
molecules were removed, polar hydrogens and partial charges
were added explicitly, whereas the program automatically adds
other hydrogens.
The modified structure of the human δ opioid receptor
was used as a model for the docking procedure with software
AutoDock Vina 1.2 (Trott and Olson, 2010). The docking pro-
tocol was initially set to rigid condition with a size of the dock
grid of 24× 24× 28Å, which encompasses the binding site for
naltrindole. Exhaustiveness was initially set to 10 with all other
parameters set on default values, then was increased to 20 for
final dockings. Molecular models of an independently built nal-
trindole and of two conformers fromNMR calculations (Amodeo
et al., 1998) were used for virtual screening. All calculations were
done on a 64 GPU Dell Cluster using 128 GB of RAM. The
top-ranked complexes, sorted by binding energy values, were
visually inspected for good stereochemical geometry and dock-
ing. For visualization, docking poses generated by AutoDock
Vina were directly loaded into PyMol (http://www.pymol.org)
through PyMOL Autodock/Vina Plugin (Seelier and de Bert,
2010). Images of the modeled receptor-ligands complexes were
produced by PyMol and AutoDockTools 1.5.6.
DOCKING ENERGY ANALYSIS
Evaluation of the docking results was done using DrugScore
Xtented (DSX) (Neudert and Klebe, 2011): the software estimates
the binding energy of the pose of the ligand bound to the delta-
opioid binding site by using a knowledge-based scoring function.
DSX-score uses statistical pair potentials derived from Cambridge
Structural Database (CSD) (Velec et al., 2005) and from PDB.
Moreover, associated to PDB potential, Solvent Accessible Surface
potential (SAS-potential) is introduced in DSX-score in order
to account for desolvation effects. PDB and SAS potentials were
used in this work. The ligand with the larger negative score has a
theoretical higher affinity.
The two models for the final complexes of conform-
ers A and B have been deposited in the PMDB database
(http://bioinformatics.cineca.it/PMDB) with accession numbers
PM0079713 and PM0079714.
RESULTS
CHOICE OF HYPOTHETICAL BIOACTIVE CONFORMERS
The main conformations of enkephalin found in crystals
(Deschamps et al., 1996) have been classified in three categories,
described as “extended,” “single bend,” and “double bend.” The
conformers shown in Figure 1 are characterized by the values of
φ/ψ angles reported in Table 1S (Supplementary Material), repre-
senting averages of the values reported in Table IIa of Deschamps
et al. (1996) for each of the X-ray structures representative of
“extended,” “single bend,” and “double bend” conformations.
As discussed in the introduction, aqueous solutions of
enkephalin contain entangled mixtures of a very large num-
ber of quasi isoenergetic conformations. To disentangle puta-
tive bioactive conformers among these conformations we have
proposed a so-called reverse strategy (Amodeo et al., 1998).
The δ selective rigid compounds used as conformational sieves
were 7-spiroindanyloxymorphone (SIOM), the first selective
non-peptide δ1 opioid agonist (Portoghese et al., 1993) and
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FIGURE 1 | Molecular models of Leu-enkephalin in the three main
conformations (extended, single bend, double bend) found in solid
state determinations of simple opioids (Deschamps et al., 1996) and
the six main conformations (A–F) found in solution when the peptide
is dissolved in a DMSO/water cryomixture at 275 K (Amodeo et al.,
1998). All models are shown as stick and balls with carbon atoms as green
balls, nitrogen atoms as blue balls, and oxygen atoms as red balls. Models
were generated with Chem3D (trial version 11).
BW373U86, a δ opioid agonist (Chang et al., 1993), novel at the
time, with a piperazinyl-diphenylmethane skeleton characterized
by aμ/δ selectively comparable to that of DPDPE (Calderon et al.,
1994).
The conformations selected using the conformational sieves
are characterized by the values of φ/ψ angles reported in Table 2S
(Supplementary Material) (Amodeo et al., 1998). A suitable mix-
ture of only two of these conformers (A and B) could account for
experimental NOEs. It is obvious that experimental NOEs rep-
resent average values for all rapidly interconverting conformers
in the distribution. For the sake of completeness, four additional
conformers (C, D, E, F) were also considered as part of a very sim-
ple equilibrium mixture because, albeit not necessary to account
for the NOEs, they are of comparable energy with respect to
A, B. The molecular models of all these solution conformers,
whose mixture can account for NMR data, are shown in Figure 1
alongside the solid state conformers.
INSIDE THE ACTIVE SITE
Granier et al. (2012) have characterized in detail the active site
of the δ-OR-T4L, which can be described as an exposed bind-
ing pocket, similar in shape to those previously observed for two
other opioid receptors. A peptide as conformationally flexible as
enkephalin can, in principle, adopt the ideal conformation to
suit the receptor requirements even after entering the cavity: a
paradigmatic case of induced fit. However, this induced fit might
be slow if the starting conformation clashes severely with the
walls of the cavity. It would be advantageous for the fit to deal
with preselected conformers with a shape closer to the bioac-
tive conformation. We decided to explore the compatibility of the
enkephalin conformations described above with the shape of the
binding pocket.
The receptor used for this comparison is the human δ receptor
recently solved by Fenalti et al. (2014). The first step was to super-
impose the tyrosine ring of enkephalin (in a given conformation)
with the corresponding ring of the naltrindole message domain.
The examples concerning the solid state conformations are shown
in Figure 1S of Supplementary Material. None of the solid state
conformers displayed in Figure 1S can be directly accommo-
dated in the receptor without clashes. In particular, the extended
conformation invades completely helix V of the receptor, the sin-
gle bend goes across helix VII and the double bend conformer
invades helix V. In addition, all models have the aromatic rings
of Tyr1 and Phe4 wide apart in space, a feature at variance with
the shape of naltrindole and/or the shape of δ selective agonists
like SIOM (Portoghese et al., 1993) or BW373U86 (Chang et al.,
1993). On the contrary, as shown in Figure 2S of Supplementary
Material, some of the conformers found in the solution study look
more promising. Although none of them fits into the pocket of
the active site without clashes, most of them have the aromatic
rings of Tyr1 and Phe4 in a relative spatial position consistent
with that of δ selective agonists. In addition, most of them suf-
fer from a comparatively less dramatic number of clashes with
respect to the solid state conformers. Altogether, compact con-
formers look more promising than extended ones, in particular
conformers A and B (Amodeo et al., 1998) have fewer clahes but,
even more significantly, account for NMR NOEs observed at low
temperature (Amodeo et al., 1998).
The model at the top of Figure 2 hosts the A conformer of
enkephalin superimposed to the molecule of naltrindole inside
the active site of the δ receptor. Superposition was achieved using
the tyrosine aromatic ring and the corresponding aromatic ring
of naltrindole. The two models in the middle and at the bot-
tom show partial views of the receptor site hosting naltrindole
and enkephalin, respectively. The molecular models on the right
are those of naltrindole and Leu-enkephalin (A), either superim-
posed (top) or separated in the same orientation as seen inside
the receptor. The models were generated with MOLMOL (Koradi
et al., 1996).
On visual inspection, the best conformer, as can be appreci-
ated from the pictures of Figure 2S and of Figure 2, is conformer
A. It has only a few clashes with helix 6 of the receptor and has a
good overall similarity with the shape of naltrindole, because of
the close proximity of the aromatic rings of Tyr1 and Phe4. The
second best is conformer B. Therefore, we have further checked
whether the interaction with the receptor walls could be opti-
mized by small adjustments of the molecular models of these two
conformers and/or changes of the side chain conformations of
relevant residues of the receptor site.
DOCKING
All conformers chosen as paradigmatic examples from conforma-
tional studies that preceded the unveiling of the structure of the
www.frontiersin.org October 2014 | Volume 1 | Article 14 | 3
Sanfelice and Temussi Bioactive conformation of enkephalin
receptor are not perfect fits and indeed it would be very surprising
if they were. What needs to be done to fit them inside the recep-
tor without significant clashes? Is it at all feasible to make them
fully consistent with the receptor requirements with a minimum
of readjustment? To answer this question we chose conformers A
and B from the quoted solution study (Amodeo et al., 1998) and
performed their docking with three different starting strategies.
Docking of naltrindole
To initially test the efficiency of the docking software (AutoDock
Vina), and to define the appropriate docking grid, we tried to
FIGURE 2 | Molecular model of conformer A of Leu-enkephalin found
in solution (Amodeo et al., 1998) inside the active site of the receptor
(pdb id 4N6H). The orientation is the result of the superposition of heavy
atoms of the tyrosine ring to the corresponding atoms of naltrindole. Both
enkephalin and naltrindole are shown as atom models. The carbon atoms of
the tyrosine moiety are colored in green (dark green for enkephalin and pale
green for naltrindole); the positive nitrogen atom is colored dark blue in
enkephalin and pale blue in naltrindole; the oxygen of the tyrosine ring is
dark red in enkephalin and pale red in naltrindole. Remaining atoms are all
yellow in enkephalin and white in naltrindole. The receptor is shown
schematically by drawing the main trans-membrane helices as cylinders
(I–VII). All models were generated by MOLMOL (Koradi et al., 1996).
dock naltrindole in a receptor previously deprived of “its” nal-
trindole. Instead, we used for naltrindole a molecular model
generated with ChemDraw (2008). The molecular model of nal-
trindole was prepared for docking using AutoDockTools, impos-
ing the rigidity of all bonds. Calculations converged to a position
of naltrindole virtually identical to that observed in the crystal
(4N6H), with a very good value of the affinity, as defined by
the main software or by an evaluation software (DSX). The vir-
tual screening results, obtained from AutodockVina, summarized
in Table 1, were sorted on the basis of their predicted binding
free energies (column labeled “Affinity”). In Table 1, together
with the values of affinity directly furnished by AutoDock Vina,
are reported the corresponding scores obtained with DSX (col-
umn labeled “Score”), a software that analyzes the output of
Autodock. DSX estimates the relative binding energy of the
Table 1 | Virtual screening and docking energy analysis.
AutoDock Vina DSX
Mol Posea Affinityb Score PCSd
(Kcal/mol) (Kcal/mol)c
Naltrindole 1 −13.6 −144.989 −0.226
2 −11.0 −109.005 −0.218
A - rigid 1 24.1 77.423 0.068
B - rigid 1 30.1 124.149 0.135
A flex 1 −7.6 −161.644 −0.166
2 −7.5 −154.517 −0.163
3 −7.5 −148.151 −0.152
4 −7.5 −147.154 −0.166
B flex 1 −7.9 −161.321 −0.170
2 −7.4 −153.970 −0.164
3 −7.4 −152.024 −0.152
4 −7.3 −151.257 −0.169
A (flex receptor) 1 −11.1 −112.435 −0.198
2 −11.0 −109.233 −0.194
3 −10.8 −106.120 −0.201
4 −10.6 −103.971 −0.187
B (flex receptor) 1 −10.6 −104.742 −0.191
2 −10.4 −103.128 −0.187
3 −10.2 −101.951 −0.188
4 −10.0 −99.873 −0.175
Poses obtained from AutoDock Vina are sorted on the basis of their predicted
binding free energy (Affinity). The DSX energy (Score) is the total score including
possible torsion and intramolecular contributions of the various configurations in
the opioid receptor. Per Contact Score (PCS) is the score divided by the number
of atom–atom interactions having any contribution in the final score (number of
contacts within 6Å´).
aNumber of poses classified by energy levels provided by AutoDock Vina.
bCalculated Energy of interaction.
cPredicted Energy (Score) of interaction.
d PCS, Per Contacts Score.
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ligands in the various configurations in the opioid receptor.
The energy reported is the total score including possible tor-
sion and intramolecular contributions; Per Contact Score (PCS)
is the score divided by the number of atom–atom interactions
having any contribution in the final score (number of contacts
within 6 Å).
The values of these two parameters were then used to gauge the
results with enkephalin conformers. Interestingly, the results of
the docking of naltrindole produced two poses: the one with the
lowest energy, pose 1, is identical to the crystallographic structure
(see Figure 3A where the crystallographic molecule is colored in
pink and the added one is shown in green), the second pose (the
purple molecule of Figures 3A,B) has an energy comparable with
that of pose one (see Table 1) and is tilted by approximately 90
degrees around a vertical axis passing through the cyclopropane
ring (Figure 3B). The portion of space occupied inside the bind-
ing cavity by the tilted ligand is roughly the same but relevant
moieties are oriented in a different way. Figure 3A, alongside the
models of naltrindole, shows the sidechains of the residues clos-
est to naltrindole (D128, Y129, N131, M132, W274, H278, Y308),
chosen from the analysis of Ligplot+ (Figure 3S of Supplementary
Material).
Docking of rigid conformers
Conformers A and B (see Figure 1) from the work of Amodeo
et al. (1998) were chosen for further docking studies. Initially the
two conformations of enkephalin were considered rigid in the
virtual screening, i.e., assuming that no bonds are rotatable. As
expected, the two conformations, although occupying a portion
of space close to that of naltrindole, did not dock relevant moi-
eties (aromatic rings and positive nitrogen) in the places found
for naltrindole (Figures 3C,D) and led to poses of very high
energy if compared with the reference value of naltrindole (see
Table 1).
Docking of flexible enkephalin conformers
It is clear that docking rigid models of enkephalin in a rigid bind-
ing site has few chances of success. Our next step was to allow
for almost complete flexibility of the peptide ligand, keeping the
receptor rigid. Docking was started from conformations A and B.
In both calculations nearly full flexibility was allowed, meaning
that carbon–carbon bonds could rotate freely around the bond
axis, while peptide bonds and aromatic rings were kept rigid. Both
calculations lead to poses comparable in energy and geometry.
Affinities and Scores are much lower than those obtained with
rigid conformers but still higher than those of the naltrindole
benchmark. It is possible to observe that the aromatic rings of
enkephalin have a tendency to occupy the hydrophobic patches
of the binding site. One of the poses for each starting conformer,
i.e., A-4 and B-4 of Figure 4S (Supplementary Material), presents
the aromatic rings in a relative orientation consistent with the
geometry of naltrindole. The torsion angles of the two conform-
ers diverge from those of the starting conformations but are not
the same and cannot be classified in terms of canonical bends.
This result is the umpteenth indication of the extreme flexibility
of enkephalin. Figure 4S and Table 1 summarize the results for
four of the lower energy results.
FIGURE 3 | Docking of the rigid ligands to the 4N6H protein. (A)
Molecular models of naltrindole docked on the rigid receptor. The molecular
model found in the original crystal structure is shown as a stick model with
carbon–carbon bonds colored in pink; the model corresponding to pose
number 1 (green) coincides perfectly with the crystallographic one. The
model corresponding to pose number 2 is shown with purple
carbon–carbon bonds. (B) Relative orientation of the models of naltrindole
corresponding to poses number 1 and 2. Rotations around vertical and
horizontal axes are indicated to facilitate the recognition. (C) Final position
of conformer A, docked as a rigid body inside the receptor cavity. The
molecular model is shown as a stick model with carbon–carbon bonds
colored in green, but for the aromatic rings of Y1 and F4, shown in white.
The two aromatic rings are at the top of the cavity, far from the
corresponding rings of naltrindole in the crystal structure. (D) Final position
of conformer B, docked as a rigid body inside the receptor cavity. The
molecular model is shown as a stick model with carbon–carbon bonds
colored in dark pink, but for the aromatic rings of Y1 and F4, shown in white.
The two aromatic rings are at the bottom of the cavity, roughly in the same
portion of space with respect to the corresponding rings of naltrindole.
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FIGURE 4 | Docking with flexible receptor for side chains. (A) Level of
flexibility for side-chains of the selected seven amino-acids is indicated by
the superposition of their sidechains in the four lowest energy poses.
Sidechains of seven critical residues of the active site of the receptor are
represented as thin stick models and labeled with single letter notation:
(Continued)
FIGURE 4 | Continued
D128, Y129, N131, M132, W274, H278, and Y308. (B) Same view as (A)
with the active site hosting the model of naltrindole in the original X-ray
structure (red stick representation). (C) Lowest energy pose for the
complex of rigid conformation A of enkephalin inside the active site of the
receptor. The molecular model of conformer A is represented as sticks
model in which the carbon–carbon bonds are colored green. (D) Lowest
energy pose for the complex of rigid conformation B of enkephalin inside
the active site of the receptor, shown together with the original naltrindole
X-ray structure. The molecular model of conformer B is represented as
sticks model in which the carbon–carbon bonds are colored green.
Docking with flexible receptor’s side chains
It is possible, from the analysis of Ligplot+, to identify seven
residues lining the walls of the active site of the receptor that
are most likely to interact with ligands. In the final stage of our
docking calculations we allowed the sidechains of D128, Y129,
N131, M132, W274, H278, and Y308 to move freely while the
program attempted to dock rigid models of conformers A and
B of enkephalin. Interestingly the results of this screening pro-
vided at least 4 poses with energy levels comparable to those of
naltrindole. Figure 4A and Table 3S shows that the positions of
six of these sidechains changed very little in the four poses of
minimum energy. Only W274, whose indole ring flips by 180
degrees, was dislocated in a substantial way. Figure 4B shows
the same view as Figure 4A, with the addition of the molecu-
lar model of naltrindole. Figures 4C,D and Figures 5A,B show
the best poses for conformers A and B, respectively. The pairwise
r.m.s.d’s between the five side chain positions, generated by the
software when accommodating the rigid ligand, range from 0.097
to 1.43, including all seven residues. Individual views are shown
in Table 1S (Supplementary Material).
Interestingly, the pose with the lowest energy for conformer
A is forming stacking interactions with the Tryptophan of the
binding site, whereas in the crystal structure the inhibitory ring
is present in that part of space, indicating a possible difference in
the interaction between enkephalin and naltrindole. In B the low-
est energy conformation is forming a stacking interaction with
the Phenylalanine 129, as shown Figure 5B.
DISCUSSION
The search for the conformation of a small flexible peptide has
been defined in the past as “an elusive goal” (Rose et al., 1985).
This attitude was plainly justified, at the time, by the bold but
inadequate means used to find bioactive conformations of flex-
ible peptides, the “Holy Graal” of drug design. For instance,
early NMR studies just looked for the conformation in aqueous
solution (Jones et al., 1976; Roques et al., 1976), i.e., a single con-
formation consistent with NMR data, even if it was already clear
that the interior of the (then unknown) receptor was probably far
less hydrophilic than aqueous solutions (Temussi et al., 1989). Yet,
there have been somany attempts to find bioactive conformations
of peptides that it is interesting to check whether there is any rel-
evant information hidden in these studies. Do 4 or 5 decades of
conformational studies on the search for the bioactive conforma-
tion of small peptides, still hold any value? To answer this question
we chose a paradigmatic example, i.e., the bioactive conformation
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FIGURE 5 | Stacking interactions between conformers (A) and (B) and
aromatic residues of the receptor. (A) Pose with the lowest energy for
conformer A. The main stacking interaction is that of the tyrosine ring of
enkephalin (Y-1) with the aromatic sidechain of W274. (B) Pose with the
lowest energy for conformer B. The main stacking interaction is that of the
tyrosine ring of enkephalin (Y-1) with the aromatic sidechain of F129.
of enkephalin, both because of the importance of this peptide and
because the structure of its receptor has been recently determined.
We restricted our search to a small sample of conformers, the
more representative found in solid state studies (Deschamps et al.,
1996) and a few from the only solution study in which it proved
possible tomeasure a significant number of NOEs (Amodeo et al.,
1998). The result is very encouraging: some compact conformers
can occupy a region of the active site of the receptor similar to
that covered by naltrindole, the rigid antagonist co-crystallized
with the receptor (Fenalti et al., 2014).
The conformations of the best of all conformers examined, A
and B from the solution study (Amodeo et al., 1998), proved also
an excellent choice as starting conformations for docking calcula-
tion inside the receptor. Even if the sidechains of residues lining
the walls of the active site are held rigidly in the position of the
crystal structure (pdb id 4N6H), it is easy to find low energy
solutions in which crucial moieties of enkephalin end up in a
position similar to those occupied by corresponding moieties of
naltrindole in the crystal structure of the complex with the recep-
tor. The two solutions are not identical, but it is not possible to
discriminate between them on the basis of a simple in silico calcu-
lation. Even more significantly, both rigid conformers (A and B
of the solution study) can yield low energy poses with energy
score quite similar to those attained by naltrindole, provided that
a small number of sidechains in the receptor wall are free to read-
just. The presence of two glycine residues, viewed as a curse in
conformational studies, is the key chosen by evolution to favor
compact conformations in which the aromatic rings of Y1 and F4
are close in space.
Before attempting to analyze the general significance of our
findings, it is in order to critically reexamine some aspects that
lie at the base of our attempt. In our choice of the receptor we
were obviously limited by the availability of solid state structures
in which an antagonist is bound to the receptor. It is only fair
to say that in general there is no warranty that any given agonist
should bind in the same fashion of an antagonist. In particular a
linear flexible agonist may, in principle, behave quite differently
from a rigid antagonist. However, in the case of enkephalin and
naltrindole, we took advantage of the extreme similarity between
the rigid antagonist (naltrindole) and one of the rigid agonists
(SIOM) used as a conformational sieve in the original NMR paper
(Amodeo et al., 1998). The two compounds differ only by the
slightly different bulk of the N substituent (a methyl in SIOM and
a cyclopropyl in naltrindole). Therefore, it is very likely that, in
the case of this pair, the agonist and the antagonists (both very
rigid) occupy the same cavity in the receptor. This assumption
implies a mechanism in antagonism that is far from proven but
quite plausible. The bulkiness of the N substituent can prevent a
specific motion in the receptors’ helices while the bulk of the two
very similar molecules reside in the same receptor cavity. Thus,
it is likely that the different bulk of the N substituent can hinder
a specific conformational change of the receptor without altering
its global architecture.
Altogether we would like not to make too many hypotheses
on the mechanism of action of opioids solely on the basis of an
in silico study. The main goal of our paper was to show that it is
possible, at least in principle, tomake an intelligent use of solution
studies on flexible peptides.
It is important to acknowledge that a flexible agonist can
assume, inside the receptor, a conformation radically different
from that of a rigid agonist. As previously mentioned, this pos-
sibility is hinted at in our work by the finding that conformers
A and B seem to interact with different aromatic residues: W274
for conformer A and Y129 for conformer B. However, while it is
not possible to tell in a conclusive way whether either conformer
A or conformer B is the bioactive conformation of enkephalin,
it is tempting to suggest that even inside the receptor enkephalin
can interact in several related conformations, characterized by the
special proximity of its aromatic rings. An ensemble of bioactive
conformations would have obvious entropic advantages. It seems
in order to note that a huge number of experimental and theo-
retical studies performed during the last 40 years failed to hint at
any plausible bioactive conformation of enkephalin. We are very
proud that we can now show that at least one of the conformers
previously found by us in a solution study (Amodeo et al., 1998)
is a likely bioactive conformation.
We can thus conclude that the goal is less elusive than it
appeared many years ago. We can confidently affirm that solu-
tion studies of other bioactive peptides, however flexible, can
www.frontiersin.org October 2014 | Volume 1 | Article 14 | 7
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help to understand some aspects of their bioactive conformation.
The only proviso is that conformational studies be performed in
media that represent a reasonablemimic of natural environments.
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